Melissa Churchill is a Professor of Neurovirology at RMIT University, Australia. Her work utilises novel techniques to define the size, nature, regulation, and impact of the HIV reservoir in the brain. She has 100+ publications including in leading journals and is a Board Member of the International Society for Neurovirology.

Dr. Marit van Gils is focused on understanding how vaccines induce protective antibodies against viral infections, including HIV and more recently, coronaviruses. She completed her Ph.D., and postdoctoral research at the University of Amsterdam and partly at Scripps Research, San Diego, USA. Her discoveries have informed next-generation HIV vaccine designs.